Literature DB >> 19859773

Cerebellar disorders--at the crossroad of molecular pathways and diagnosis.

Mario Manto, Danielle Marmolino.   

Abstract

Our understanding of the pathogenesis of cerebellar ataxias has started several decades ago and is continuously growing. The numerous mechanisms of cerebellar dysfunction are being discovered by numerous groups of researchers worldwide. Neuronal damage results from a complex interaction of metabolic pathways, which leads to symptoms observed in cerebellar disorders. The main mechanisms at the molecular level are the following: impairment of DNA repair and replication, deregulation of transcription/deficits of processing/transport of RNA, abnormal protein transport and misfolding, aggregates both at the nuclear and cytosolic level, activation of caspases, apoptosis, involvement of autophagic mechanisms, oxidative stress and mitochondrial dysfunction, excitotoxicity, abnormal lipid metabolism, impaired axonal transport and vesicle trafficking, and defects of the neurotransmission. The convergence of the current clinical classification with molecular findings is expected. This integration is a basic substrate for the rationale development of therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19859773     DOI: 10.1007/s12311-009-0142-4

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  17 in total

Review 1.  Polyglutamine pathogenesis.

Authors:  C A Ross; J D Wood; G Schilling; M F Peters; F C Nucifora; J K Cooper; A H Sharp; R L Margolis; D R Borchelt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-06-29       Impact factor: 6.237

Review 2.  Don't get too excited: mechanisms of glutamate-mediated Purkinje cell death.

Authors:  Jennifer E Slemmer; Chris I De Zeeuw; John T Weber
Journal:  Prog Brain Res       Date:  2005       Impact factor: 2.453

Review 3.  Diagnosis and management of early- and late-onset cerebellar ataxia.

Authors:  E Brusse; J A Maat-Kievit; J C van Swieten
Journal:  Clin Genet       Date:  2007-01       Impact factor: 4.438

Review 4.  Beyond NMDA and AMPA glutamate receptors: emerging mechanisms for ionic imbalance and cell death in stroke.

Authors:  Elaine Besancon; Shuzhen Guo; Josephine Lok; Michael Tymianski; Eng H Lo
Journal:  Trends Pharmacol Sci       Date:  2008-04-01       Impact factor: 14.819

5.  Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.

Authors:  Marcel Raspe; Judith Gillis; Hilde Krol; Sabine Krom; Klazien Bosch; Henk van Veen; Eric Reits
Journal:  J Cell Sci       Date:  2009-08-18       Impact factor: 5.285

6.  The length dependence of the polyQ-mediated protein aggregation.

Authors:  Sunjay Barton; Ron Jacak; Sagar D Khare; Feng Ding; Nikolay V Dokholyan
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

7.  The clinical diagnosis of autosomal dominant spinocerebellar ataxias.

Authors:  Thomas Klockgether
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

Review 8.  Emerging pathogenic pathways in the spinocerebellar ataxias.

Authors:  Kerri M Carlson; J Michael Andresen; Harry T Orr
Journal:  Curr Opin Genet Dev       Date:  2009-04-01       Impact factor: 5.578

9.  Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction.

Authors:  Dominique Helmlinger; Sara Hardy; Gretta Abou-Sleymane; Adrien Eberlin; Aaron B Bowman; Anne Gansmüller; Serge Picaud; Huda Y Zoghbi; Yvon Trottier; Làszlò Tora; Didier Devys
Journal:  PLoS Biol       Date:  2006-02-28       Impact factor: 8.029

Review 10.  Spinocerebellar ataxias caused by polyglutamine expansions: a review of therapeutic strategies.

Authors:  Benjamin R Underwood; David C Rubinsztein
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

View more
  6 in total

1.  An electrophysiological study of visual processing in spinocerebellar ataxia type 2 (SCA2).

Authors:  Jan Kremlacek; Martin Valis; Jiri Masopust; Ales Urban; Alena Zumrova; Radomir Talab; Miroslav Kuba; Zuzana Kubova; Jana Langrova
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

2.  MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils.

Authors:  Vesna Selakovic; Branka Janac; Lidija Radenovic
Journal:  Mol Cell Biochem       Date:  2010-04-27       Impact factor: 3.396

3.  ELOVL5 mutations cause spinocerebellar ataxia 38.

Authors:  Eleonora Di Gregorio; Barbara Borroni; Elisa Giorgio; Daniela Lacerenza; Marta Ferrero; Nicola Lo Buono; Neftj Ragusa; Cecilia Mancini; Marion Gaussen; Alessandro Calcia; Nico Mitro; Eriola Hoxha; Isabella Mura; Domenico A Coviello; Young-Ah Moon; Christelle Tesson; Giovanna Vaula; Philippe Couarch; Laura Orsi; Eleonora Duregon; Mauro Giulio Papotti; Jean-François Deleuze; Jean Imbert; Chiara Costanzi; Alessandro Padovani; Paola Giunti; Marcel Maillet-Vioud; Alexandra Durr; Alexis Brice; Filippo Tempia; Ada Funaro; Loredana Boccone; Donatella Caruso; Giovanni Stevanin; Alfredo Brusco
Journal:  Am J Hum Genet       Date:  2014-07-24       Impact factor: 11.025

4.  Intracerebellar application of P19-derived neuroprogenitor and naive stem cells to Lurcher mutant and wild type B6CBA mice.

Authors:  Zbyněk Houdek; Jan Cendelín; Vlastimil Kulda; Václav Babuška; Miroslava Cedíková; Milena Králíčková; Jiří Pacherník; George B Stefano; František Vožeh
Journal:  Med Sci Monit       Date:  2012-05

Review 5.  Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.

Authors:  Lauren M Watson; Maggie M K Wong; Esther B E Becker
Journal:  Open Biol       Date:  2015-07       Impact factor: 6.411

6.  Cerebrospinal Fluid Biomarkers in Spinocerebellar Ataxia: A Pilot Study.

Authors:  Ashley M Brouillette; Gülin Öz; Christopher M Gomez
Journal:  Dis Markers       Date:  2015-07-22       Impact factor: 3.434

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.